4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-20-029951
Options or other derivatives
- Director acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cheng Isaac · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-29 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +80,000 | 80,000 | D |
Loading xslF345X03/doc4.xml…